ABEO: Sells Priority Review Voucher for 155 Million
On May 15, 2025, Abeona Therapeutics, Inc. (ABEO) announced financial results for the first quarter of 2025 and provided a business...
349 Views
ABEO: Zevaskyn Approved by FDA Raising Valuation to 11
On April 29, 2025, Abeona Therapeutics, Inc. (ABEO) announced that the U.S. Food and Drug Administration (FDA) has approved Zevaskyn (prademagene...
438 Views
ABEO: Countdown to PDUFA Date of April 29, 2025
On March 20, 2025, Abeona Therapeutics, Inc. (ABEO) announced financial results for the fourth quarter and full year of 2024 and provided a...
378 Views
ABEO: FDA Accepts BLA Re-Submission for Pz-cel PDUFA Date of April 29
On November 14, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the third quarter of 2024 and provided a business...
281 Views
ABEO: Type A Meeting with FDA Concluded BLA Submission on Track for 2H24
On August 12, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the second quarter of 2024 and provided a business...
260 Views